Search

everythinglearnresearchcommunity

for

Search:↓

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Vitamin D receptor is crucial for starting hair growth after birth.

Bcl-2 overexpression protects against UVB damage but worsens hair loss from chemotherapy.

ALA-photodynamic therapy helps reduce acne by causing acne cell death and lowering certain skin protein levels.

Organoids can help study COVID-19 and develop treatments, but face challenges like instability and limited renewal.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

Fat stem cells from diabetic mice can still help heal wounds.

Serum formulations were better at delivering molecules to the hair bulb than nanoparticles.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

The meeting highlighted the genetic basis of female pattern hair loss and various skin health insights.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Glycemic control medications for Type 2 diabetes can affect skin conditions like psoriasis.

COVID-19 is caused by a virus from bats, and efforts focus on prevention and treatment research.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

A new method using human lung cells helps find drugs to block and reduce inflammation from SARS-CoV-2.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Researchers created a mouse model of a type of rickets that does not cause hair loss.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

t-Flavanone may help hair growth by reducing a specific protein's activity in skin cells.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Vitamin D deficiency is common in temporary hair loss, and stress is often a suspected cause.

Continuous glucose monitoring and GLP-1 receptor agonists improve diabetes management, but personalized care and education are crucial.

Stem cell therapy shows promise for treating hair loss in androgenetic alopecia.